Results 91 to 100 of about 15,810 (189)
Ceftolozane-tazobactam is a novel fifth-generation cephalosporin/β-lactamase inhibitor combination recently approved for treatment of both complicated intra-abdominal and urinary tract infections in adults.
Silvia Garazzino +5 more
doaj +1 more source
Pseudomonas aeruginosa is a dangerous pathogen that has shown multidrug resistance in Sub‐Saharan Africa (SSA) and has significantly impacted healthcare, where poor infection control and limited resources are common. This narrative review examines strategies in the SSA region to control this pathogen, reports its prevalence, highlights key challenges ...
Barack Magwi Nyanswi +5 more
wiley +1 more source
Objectives: To investigate the in vitro activity of ceftazidime/avibactam and ceftolozane/tazobactam against clinical isolates of MDR Pseudomonas aeruginosa from Qatar, as well as the mechanisms of resistance. Methods: MDR P. aeruginosa isolated between
Jass, Jana +27 more
core +1 more source
Many antibiotics originate from soil‐inhabiting Actinobacteria, especially from the diverse genus Streptomyces. However, the emergence of antibiotic resistance poses a significant global challenge to treating infectious diseases. Therefore, the search for Actinobacteria, particularly from less‐explored environments, as potential sources of novel ...
Rajani Balkrishna Rao +6 more
wiley +1 more source
We tested the in vitro susceptibility of ceftazidime-avibactam and ceftolozane-tazobactam and 13 other antibiotics against 91 Burkholderia cepacia complex (BCC) strains isolated from cystic fibrosis patients since 2012.
Peeters, Charlotte +8 more
core +1 more source
Background Diabetes mellitus and hyperglycemia are associated with increased susceptibility to bacterial infections and poor treatment outcomes. This post hoc evaluation of the treatment of complicated intra-abdominal infections (cIAI) and complicated ...
Myra W. Popejoy +2 more
doaj +1 more source
In vitro susceptibility profile of BLEES-positive Enterobacteriaceae isolated from clinical specimens to ceftolozane/tazobactam [PDF]
Las Enterobacterias son un grupo grande y heterogéneo de bacterias gramnegativas, las cuales se caracterizan por su capacidad de producir infecciones en pacientes inmunocompetentes e inmunosuprimidos tanto de la comunidad como en el ambiente ...
Valderrama Rodríguez, Cristian Camilo
core +1 more source
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC. [PDF]
We compared the dynamics and mechanisms of resistance development to ceftazidime, meropenem, ciprofloxacin, and ceftolozane-tazobactam in wild-type (PAO1) and mutator (PAOMS, ΔmutS) P. aeruginosa.
Moyà, Bartolomé +7 more
core +1 more source
Ceftolozane and tazobactam for the treatment of hospital acquired pneumonia
© 2020, © 2020 Informa UK Limited, trading as Taylor & Francis Group. Introduction: Patients admitted to hospitals are at risk of developing nosocomial infections. These types of infections typically occur in immune compromised patients.
Martin-Loeches I, Bisanti A, Diaz E, Rodriguez A
core
Background: Clinical guidelines recommend two novel β-lactam/β-lactamase inhibitor combinations—ceftolozane–tazobactam and ceftazidime–avibactam—as first-line therapies for drug-resistant Pseudomonas aeruginosa infections.
Pengfei Li +3 more
doaj +1 more source

